UH

Ulrich Hersel

AA Ascendis Pharma A/S: 16 patents #2 of 38Top 6%
AA Ascendis Pharma Growth Disorders A/S: 11 patents #1 of 14Top 8%
SA Sanofi-Aventis: 5 patents #260 of 1,008Top 30%
AA Ascendis Pharma Endocrinology Division A/S: 3 patents #6 of 19Top 35%
BG Biomet Deutschland Gmbh: 2 patents #4 of 30Top 15%
Overall (All Time): #71,787 of 4,157,543Top 2%
42
Patents All Time

Issued Patents All Time

Showing 1–25 of 42 patents

Patent #TitleCo-InventorsDate
12377133 Dry pharmaceutical formulations of CNP conjugates Anja R. H. Skands, Charlotte Pinholt, Stefan Heinig 2025-08-05
12274737 PEGylated recombinant human growth hormone compounds Harald Rau, Susanne Kindermann, Torben Leßmann, Grethe Norskov Rasmussen, Thomas Wegge +1 more 2025-04-15
12239689 Controlled-release CNP agonists with low initial NPR-B activity Kennett Sprogøe, Harald Rau, Felix Cleemann 2025-03-04
12156917 CNP prodrugs with carrier attachment at the ring moiety Harald Rau, Felix Cleemann, Kennett Sprogøe 2024-12-03
12083182 Controlled-release CNP agonists with increased NEP stability Kennett Sprogøe, Harald Rau, Felix Cleemann 2024-09-10
11559482 Biodegradable polyethylene glycol based water-insoluble hydrogels Harald Rau, Mathias Krusch, Dirk Vetter, Tobias Voigt 2023-01-24
11413351 CNP prodrugs with carrier attachment at the ring moiety Harald Rau, Felix Cleemann, Caroline Elisabeth Rasmussen 2022-08-16
11389510 Controlled-release CNP agonists with low initial NPR-B activity Kennett Sprogøe, Harald Rau, Felix Cleemann, Caroline Elisabeth Rasmussen 2022-07-19
11389511 Controlled-release CNP agonists with reduced side-effects Kennett Sprogøe, Harald Rau, Felix Cleemann, Caroline Elisabeth Rasmussen 2022-07-19
11311604 Controlled-release CNP agonists with low NPR-C binding Harald Rau, Kennett Sprogøe, Frank Faltinger, Thomas Wegge, Felix Cleemann 2022-04-26
11224661 Controlled-release CNP agonists with increased NEP stability Kennett Sprogøe, Harald Rau, Ana Bernhard, Felix Cleenmann, Thomas Wegge 2022-01-18
11154593 CNP prodrugs with large carrier moieties Harald Rau, Felix Cleemann, Caroline Elisabeth Rasmussen 2021-10-26
11116849 Hydrogel-linked prodrugs releasing tagged drugs Harald Rau, Nora Kaluza, Thomas Knappe, Burkhardt Laufer 2021-09-14
10980860 Diagnosis, prevention and treatment of diseases of the joint Dirk Vetter, Kennett Sprogøe, Nora Kaluza, Oliver Keil, Guillaume Maitro +1 more 2021-04-20
10960053 PEGylated recombinant human growth hormone compounds Harald Rau, Susanne Kindermann, Torben Leßmann, Grethe Norskov Rasmussen, Thomas Wegge +1 more 2021-03-30
10835578 CNP prodrugs with large carrier moieties Harald Rau, Felix Cleemann, Caroline Elisabeth Rasmussen 2020-11-17
10729778 Carrier-linked treprostinil prodrugs Harald Rau, Torben Lessmann, Nicola Bisek, Guillaume Maitro, Kennett Sprogøe +3 more 2020-08-04
10098930 PEGylated Recombinant Human Growth Hormone Compounds Harald Rau, Susanne Kindermann, Torben Lebmann, Grethe Norskov Rasmussen, Thomas Wegge +1 more 2018-10-16
10029015 Hydrogel formulations Harald Rau, Robert Schnepf, Dirk Vetter, Thomas Wegge 2018-07-24
9913912 Carrier-linked prostanoid prodrugs Harald Rau, Guillaume Maitro, Oliver Keil, Thomas Wegge 2018-03-13
9872864 Sustained release composition of prostacyclin Kennett Sprogøe, Harald Rau, Thomas Wegge, Oliver Keil, Joachim Zettler 2018-01-23
9561287 Carrier-linked treprostinil prodrugs Harald Rau, Torben Lessmann, Nicola Bisek, Guillaume Maitro, Kennett Sprogøe +3 more 2017-02-07
9457066 Prodrugs comprising an insulin linker conjugate Harald Rau, Felix Cleemann, Silvia Kaden-Vagt, Torben Lessmann, Thomas Wegge 2016-10-04
9353170 Long-acting transient polymer conjugates of exendin Harald Rau, Dirk Vetter, Thomas Wegge 2016-05-31
9278139 Sterilization of biodegradable hydrogels Harald Rau, Tobias Voigt 2016-03-08